Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 71Thoracic 31Genitourinary 29Gynecologic 24Breast 23Other hematologic neoplasm 21Lymphoid 21Head & Neck 18CNS 14Dermatologic 11Sarcoma 9Tumor-Agnostic 7Plasma cell 7Myeloid 6Endocrine 6Other 4Classical hematology 4Other solid neoplasm 3Other neoplasm 2

Conditions

Prostatic Neoplasms 1Precancerous Conditions 1Cancer-Related Condition 1

Interventions

Cyclophosphamide 13Biopsy 13fludarabine phosphate 9Whole-Body Irradiation 9Surveys and Questionnaires 9Peripheral Blood Stem Cell Transplantation 9Busulfan 9Polymerase Chain Reaction 7Mycophenolic Acid 7Early Intervention, Educational 7Tacrolimus 6Gene Expression Profiling 6Educational Status 6Colposcopy 6Carboplatin 6fludarabine 5Paclitaxel 5Microarray Analysis 5Methotrexate 5Methods 5Melphalan 5Immunohistochemistry 5Epoetin Alfa 5Decitabine 5Cyclosporine 5Cisplatin 5Celecoxib 5Antilymphocyte Serum 5Aminolevulinic Acid 5Sulindac 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observation × Other neoplasm × Clear all
NCT04843657 2021-04-13

Precise Care for Cancer Related Fatigue

Taipei Medical University

Unknown
200 enrolled
Other neoplasm

Cancer-Related Condition

NCT00118066 2015-05-27

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Rutgers, The State University of New Jersey

Phase 2 Terminated
12 enrolled
GenitourinaryOther neoplasm

Precancerous Conditions, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡